Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 06, 2020

SELL
$26.16 - $63.5 $78,480 - $190,500
-3,000 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$46.96 - $61.67 $140,880 - $185,010
3,000 New
3,000 $263,000
Q4 2018

Feb 12, 2019

SELL
$59.1 - $93.26 $109,807 - $173,277
-1,858 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$88.86 - $117.49 $165,101 - $218,296
1,858 New
1,858 $271,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $33.9M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.